Current situation and prospect in the clinical treatment of gallbladder cancer
10.3760/cma.j.cn115610-20230109-00013
- VernacularTitle:胆囊癌临床治疗的现状与展望
- Author:
Yingbin LIU
1
;
Wei CHEN
Author Information
1. 上海交通大学医学院附属仁济医院胆胰外科，上海 200127
- Keywords:
Gallbladder carcinoma;
Surgical procedures, Operative;
Evaluation;
Neo-adjuvant;
Conversion
- From:
Chinese Journal of Digestive Surgery
2023;22(1):81-88
- CountryChina
- Language:Chinese
-
Abstract:
Gallbladder carcinoma is a tumor with poor prognosis and lack of effective comprehensive treatment. At present, surgical resection is still the main treatment for gallbladder carcinoma. Precise evaluation and adequate preparation before surgery, and safe, effective, standar-dized resection are the key points to successful treatment of gallbladder carcinoma. In clinic, there has been a growing appreciation of the prevention and reasonable treatment of incidental gallbladder carcinoma. Neoadjuvant and conversion therapy give full play to the effects of chemotherapy, targeted therapy, and immunotherapy agents on tumor cells, which can achieve the goal of downstage or conversion of tumors before surgery, increasing the radical resection rate, and improving the prognosis of patients.
